ICVX - Icosavax, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Seattle,
United States
Type: Equity
ICVX price evolution
ICVX
| (in millions $) | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $63.2 | $155.07 | $49.34 | $58.85 |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $235.3 | $251.7 | $202.17 | $223.91 |
| Long term investments | ||||
| Property, plant & equipment | $14.4 | $15.2 | $15.39 | $14.76 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $251.3 | $269.03 | $219.67 | $238.68 |
| Current liabilities | ||||
| Accounts payable | $1.2 | $1.55 | $1.61 | $2.89 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $13 | $15.01 | $12.9 | $13.79 |
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $18.9 | $21.3 | $19.59 | $20.52 |
| Shareholders' equity | ||||
| Retained earnings | -$258.9 | -$236.88 | -$210.39 | -$185.83 |
| Other shareholder equity | -$0.07 | -$0.06 | -$0.4 | |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 | 31 Jan 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $58.85 | $279.08 | $13.11 | $23.08 |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $223.91 | $286.55 | $16.16 | $23.29 |
| Long term investments | ||||
| Property, plant & equipment | $14.76 | $1.08 | $0.01 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $238.68 | $287.63 | $16.17 | $23.29 |
| Current liabilities | ||||
| Accounts payable | $2.89 | $3.9 | $1.92 | $0.8 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $13.79 | $9.24 | $5.83 | $1.22 |
| Long term debt | $4.95 | |||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $20.52 | $9.41 | $12.81 | $1.47 |
| Shareholders' equity | ||||
| Retained earnings | -$185.83 | -$94.07 | -$27.1 | -$8.24 |
| Other shareholder equity | -$0.4 | |||
| Total shareholder equity | ||||